Logo
x

Search

Subscribe Now

QUAZAR AML-001

BMS' Onureg (azacytidine) Receives EC's Approval for as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

BMS' Onureg (azacytidine) Receives EC's Approval for as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

  • June 21, 2021
Celgene Reports Results of CC-486 in P-III QUAZAR AML-001 Study as Maintenance Therapy for Acute Myeloid Leukemia

Celgene Reports Results of CC-486 in P-III QUAZAR AML-001 Study as Maintenance Therapy for Acute Myeloid Leukemia

  • September 13, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.